Hopefully, we find out very soon where things are at with
Hopefully, we find out very soon where things are at with the IND, the IPO ( long overdue), and all the other Generex/NuGenerex initiatives.
Since the FDA doesn’t send an approval letter for an IND ( 30 day window) and we have not heard about the human trials starting, so many questions are in the air.
Was the IND submitted? If it was submitted, when did that happen?
If it was submitted, has there been any communication ( Clinical Hold) from the FDA before trials can start?
Is the IND holding up the IPO, or are these mutually exclusive events?
Four months since the last CC…why does all of this have to be such a secret?
6
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Arcutis' ZORYVE® Celebrated with Allure's Esteemed Award Arcutis Biotherapeutics, Inc. proudly announces that its groundbreaking medication, ZORYVE® (roflumilast), has been awarded the highly esteemed Allure Best of Beauty Breakthrough Award. This recognition marks ZORYVE as a pioneering product, being the first FDA-approved topical treatment for atopic dermatitis,...
Continue Reading
West Monroe Appoints John Rosato to Transform Technology Division Firm invests to rapidly scale its technology prowess, building on an already strong foundation of experienced capabilities and leadership. West Monroe, a global business and technology consulting firm, is pleased to announce the appointment of John Rosato as its new lead for Technology & Experience. With...
Continue Reading
Gemini Space Station Announces Initial Public Offering Gemini Space Station, Inc. today declared its intention to conduct an initial public offering, offering 16,666,667 shares of Class A common stock as part of a filing submitted to the U.S. Securities and Exchange Commission (SEC). The company aims to solidify its place within the competitive crypto market through this...
Continue Reading
Overview of Public Disclosure in the Context of Renewi Plc The disclosure of ownership positions is crucial under the Takeover Code. Companies, like Renewi Plc, need to comply with strict regulations to inform the public about their shareholders and significant ownership stakes. This article delves into the recent disclosure made by Rathbones Group Plc regarding their...
Continue Reading
Important Update for Nextracker Investors In recent events, Nextracker Inc. has found itself at the center of a class action securities lawsuit, making it crucial for investors to stay informed about their rights and potential actions. This comes from Levi & Korsinsky, LLP, a law firm with significant experience in handling complex securities litigation. Understanding the...
Continue Reading
